0002102340-25-000001.txt : 20251222 0002102340-25-000001.hdr.sgml : 20251222 20251222163823 ACCESSION NUMBER: 0002102340-25-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251222 DATE AS OF CHANGE: 20251222 EFFECTIVENESS DATE: 20251222 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Addition Therapeutics, Inc. CENTRAL INDEX KEY: 0002102340 ORGANIZATION NAME: EIN: 871269401 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-567798 FILM NUMBER: 251592986 BUSINESS ADDRESS: STREET 1: 201 HASKINS WAY, SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6504302889 MAIL ADDRESS: STREET 1: 201 HASKINS WAY, SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 D 1 primary_doc.xml X0708 D LIVE 0002102340 Addition Therapeutics, Inc. 201 HASKINS WAY, SUITE 300 SOUTH SAN FRANCISCO CA CALIFORNIA 94080 650-430-2889 DELAWARE None None Corporation true 2021 Ronald Park 201 Haskins Way, Suite 300 South San Francisco CA CALIFORNIA 94080 Executive Officer Director Peter Bisgaard 201 HASKINS WAY, SUITE 300 South San Francisco CA CALIFORNIA 94080 Director Kathleen Collins 201 HASKINS WAY, SUITE 300 South San Francisco CA CALIFORNIA 94080 Director Matthew Patterson 201 HASKINS WAY, SUITE 300 South San Francisco CA CALIFORNIA 94080 Director Laetitia Schwab 201 HASKINS WAY, SUITE 300 South San Francisco CA CALIFORNIA 94080 Director Jennifer Lee 201 HASKINS WAY, SUITE 300 South San Francisco CA CALIFORNIA 94080 Director Jayson Punwani 201 HASKINS WAY, SUITE 300 South San Francisco CA CALIFORNIA 94080 Director Lawrence Kong 201 HASKINS WAY, SUITE 300 South San Francisco CA CALIFORNIA 94080 Executive Officer Biotechnology Decline to Disclose 06b false 2025-12-11 false true true true false 0 28000000 28000000 0 false 9 0 0 0 false Addition Therapeutics, Inc. Lawrence Kong Lawrence Kong Secretary 2025-12-22